About Rational Vaccines
Rational Vaccines is a Healthcare company based in Springfield (United States) founded in 2015 by Agustin Fernandez. Vaccines and diagnostics for herpes-related diseases are developed. Rational Vaccines has raised $30.62 million across 9 funding rounds from investors including HHS. The company has 18 employees. Its chief executive, as recorded, is Agustin Fernandez. Rational Vaccines offers products and services including Herpes Vaccine Candidates. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral. Its legal entity is RATIONAL VACCINES, INC. Its competitors include VBI Vaccines, Tonix Pharma and HilleVax; 3 of its 3 listed competitors have raised funding.
Company details
Rational Vaccines was founded in 2015 and is based in Springfield, United States. Focus is placed on the biotechnology sector, where vaccines and diagnostics for herpes simplex virus infections are developed. Live-attenuated prophylactic and therapeutic vaccines targeting HSV-1 and HSV-2 are being prepared for human trials. A flow-cytometer-based assay for detecting HSV-specific antibodies has also been created. Operations center on advancing treatments for herpes-related conditions.
- Headquarters Springfield, United States
- Employees 18
- Founders Agustin Fernandez
- SectorsHealthcare
- Email••••••••
- Website rationalvaccines.com
- Social LinkedIn X Facebook
- Legal Name Rational Vaccines, Inc
- Total Equity Funding$30.62M (USD)
in 9 rounds
- Latest Funding Round$1.27M (USD), Grant
Aug 2023
- Investors
- Employee Count18
Products & Services of Rational Vaccines
Rational Vaccines offers a comprehensive portfolio of products and services, including Herpes Vaccine Candidates.
Live attenuated vaccines for preventing and treating HSV infections.
Funding Insights of Rational Vaccines
Rational Vaccines has successfully raised a total of $30.62M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $1.27 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30.62M
- Total Rounds 9
- Last Round Grant — $1.27M
- First Round $699,999
(Sep 2015)
- Investors Count 1
All 9 funding rounds of Rational Vaccines with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Rational Vaccines
Rational Vaccines has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Rational Vaccines
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rational Vaccines
22 people are tracked at Rational Vaccines (7 in leadership, 13 in board & advisors, 2 in team); the tracked headcount is 18.
| Name | Role | Group |
|---|---|---|
Agustin Fernandez | Founder & CEO | Leadership |
Edward Gershburg | CTO | Leadership |
Olivier Jarry | CFO | Leadership |
Kerstin Westritschnig | Chief Medical Officer | Leadership |
Konstantin Kousoulas | VP of Scientific Affairs | Leadership |
JACK DOTY | Chief Strategic Officer and Member of Board of Directors | Leadership |
Gerhard Hager | Head of Non Clinical Development | Leadership |
Paul Predki | Scientific Advisor | Board & advisors |
Lional Raj | Scientific Advisor | Board & advisors |
Georg Holländer | Scientific Advisor | Board & advisors |
Todd Margolis | Scientific Advisor | Board & advisors |
Jim Robinson | Scientific Advisor | Board & advisors |
David I. Bernstein | Scientific Advisor | Board & advisors |
John Boslego | Clinical Advisor | Board & advisors |
Mahira Hamdy El Sayed | Clinical Advisor | Board & advisors |
Rahul Singhvi | Scientific Advisor | Board & advisors |
Stanley A. Plotkin | Scientific Advisor | Board & advisors |
Luis Rios-Nogales Garces | Chair, Clinical Advisory Board | Board & advisors |
Rajul Patel | Clinical Advisor | Board & advisors |
Alan Kimura | Scientific Advisor | Board & advisors |
2 more people are available in the full profile.
Complete people profiles for Rational Vaccines
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Rational Vaccines
3 dated milestones of Rational Vaccines across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Rational Vaccines is founded.
- Funding First funding round of $700K.
- Funding Latest funding round, Grant, of $1.3M.
Competitors of Rational Vaccines
Rational Vaccines has 3 listed competitors in our database, 3 of them funded. They include VBI Vaccines, Tonix Pharma and HilleVax.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vbivaccines.com | 2001 | Cambridge, United States | $65.07M | 13 | VBI Vaccines is engaged in developing vaccines and immunotherapeutics. | |
| tonixpharma.com | 2007 | New York, United States | $4.45M | 117 | Next-generation medicines for CNS and immunological disorders are developed. | |
| hillevax.com | 2021 | Boston, United States | $135M | 62 | A norovirus vaccine is developed for infection prevention. |
Detailed competitors of Rational Vaccines
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rational Vaccines
The website of Rational Vaccines (rationalvaccines.com) receives about 1K visits a month.
- Monthly visits1K
▼ 23.9% vs previous month
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Rational Vaccines (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rational Vaccines
Complete news archive for Rational Vaccines
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rational Vaccines
Rational Vaccines was founded in 2015.
Rational Vaccines is headquartered in Springfield, United States.
Agustin Fernandez is the CEO of Rational Vaccines, as recorded in our data. They have also founded this company.
Rational Vaccines is a funded company, having raised a total of $30.62M across 9 funding rounds to date. The company's 1st funding round was a Seed of $700K, raised on Sep 2015.
Rational Vaccines has 18 employees.
Rational Vaccines was founded in 2015 and is based in Springfield, United States. Focus is placed on the biotechnology sector, where vaccines and diagnostics for herpes simplex virus infections are developed. Live-attenuated prophylactic and therapeutic vaccines targeting HSV-1 and HSV-2 are being prepared for human trials. A flow-cytometer-based assay for detecting HSV-specific antibodies has also been created. Operations center on advancing treatments for herpes-related conditions.
Rational Vaccines's top competitors include Tonix Pharma, HilleVax and VBI Vaccines.
Rational Vaccines offers Herpes Vaccine Candidates.
Rational Vaccines has 1 investor. Key investors include HHS.
Rational Vaccines operates through Rational Vaccines, Inc.